Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users
about
The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population studyFemale sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohortMany hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patientsHepatitis C infection in HIV-1 natural viral suppressors.Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseasesFactors associated with spontaneous clearance of hepatitis C virus in Chinese populationHepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index.The ongoing impacts of hepatitis c--a systematic narrative review of the literaturePhylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, CanadaThe Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control Study.Identifying and describing a cohort effect in the national database of reported cases of hepatitis C virus infection in Canada (1991-2010): an age-period-cohort analysisHIV co-infection accelerates decay of humoral responses in spontaneous resolvers of HCV infection.Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis.Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.The potential influence of KIR cluster profiles on disease patterns of Canadian Aboriginals and other indigenous peoples of the AmericasInjection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort CollaborationNatural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil.Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysisHepatitis C virus in American Indian/Alaskan Native and Aboriginal peoples of North America.Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patientsPredictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccinePlasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.Treatment of chronic hepatitis C in a Canadian Aboriginal population: results from the PRAIRIE study.Role of IL28B for chronic hepatitis C treatment toward personalized medicine.Host genetic variants influencing the clinical course of hepatitis C virus infection.Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact.Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers Cohort.The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males.Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users.Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator.The Impact of IFN-γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran.Hepatitis C cross-genotype immunity and implications for vaccine developmentThe influence of North American Aboriginal ethnicity on pro-inflammatory and anti-inflammatory cytokine responses to IFN-alpha.GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control study.Hepatitis C virus infection in Canada's First Nations people: a growing problem.
P2860
Q28476680-21E4CA18-86FD-4A70-AE4B-C80867051DDCQ28477975-B712D929-8850-43A9-808E-9337357EB5B7Q30884457-FEE18499-DAF2-4310-88C1-015DDD9F9E62Q33873986-3A0BEF47-3B73-458E-B4CA-F35919B79498Q33952520-CB6857B0-29F2-4629-A4B5-AB6E615A9395Q33997400-18D0488A-844A-4565-B581-D8B9209EDF35Q34009690-B6F0AD6F-A7A4-4151-947A-303CC5C5A8ECQ34101320-D1685A79-498E-40CE-A6D5-DC2209F157B6Q34383139-AB5E0352-5FC5-43BA-9DBA-60FD3EBC7313Q34415820-FE391B08-C736-4117-AD7A-AA2D59607629Q34546135-35A053E1-6D0B-473D-BD1F-AB51EA746C57Q34609276-8559B573-AF5C-4B78-A21B-1C0C751B431FQ34678366-1E8745E2-6B30-4CF9-B249-9F9534FD1A4CQ35197198-D4DBFCC4-95DF-4E6F-9F30-1C88F1764126Q35381792-61CF943A-3D52-4984-BE39-780BC8FB3233Q35591668-1C4B2BD4-C789-40BC-A29F-8B3D949886E0Q35864236-865FAC19-C9C5-4E37-A736-BF7386ECB81EQ36067577-77BF0A79-1FFD-4A45-B32D-591387C45869Q36119451-D1DA6256-8917-4C29-AFE4-0FFECF05C799Q36123263-0887B627-1DCB-466D-8BF1-DEE89FC1611CQ36482820-11B47FFC-2C64-4320-A59E-36CCC26F147CQ36501932-8DFE461F-B61D-41C3-91BC-67ECE0BD1443Q36698904-D966D022-006D-46AF-BA6F-1202B5AD5879Q36717008-E0600FEF-31A3-435B-9302-684A8BC71141Q36874661-67D9AFD8-61BD-45F8-A5AF-0965B14404C9Q36874791-8BE148D7-91CD-4CC5-98DF-5519868DCAACQ37558564-890E914B-270B-4891-AB6F-7B7FC3127671Q38170161-9CC95CCF-B519-497F-A4E0-A2C6FD86BFC7Q38554500-18819AF9-3430-4A7C-A1F7-69A67C039AB6Q38729837-77FBDAA4-2979-43AE-9AAB-A638E051CAA0Q39154932-E6E44CFD-AB3F-4499-8F3C-2616C8EF6B52Q39212153-775452AA-3975-4F33-AA55-3D66C22ECF49Q39269740-F0F3A30D-6837-4F2F-A6B7-06F42DC87B6BQ39285745-63B412D4-AB89-41A5-9C26-10462E96D6B9Q40101753-5F4D7F2F-2F68-4B39-AA13-FC46AFACA69BQ41216716-A3CE48FA-6654-4A41-A257-726AFD658EB6Q42364607-158890D7-EC2B-43DF-94DA-3144EA8588E2Q42984793-5478DADD-D77C-4474-A963-C8A3FF458777Q42992649-35C290D1-8300-423F-B0A7-A956136CD2EEQ43124272-8ED73174-E968-41E9-B2CF-56A326A279FD
P2860
Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Factors associated with sponta ...... virus among illicit drug users
@ast
Factors associated with sponta ...... virus among illicit drug users
@en
Factors associated with sponta ...... virus among illicit drug users
@nl
type
label
Factors associated with sponta ...... virus among illicit drug users
@ast
Factors associated with sponta ...... virus among illicit drug users
@en
Factors associated with sponta ...... virus among illicit drug users
@nl
prefLabel
Factors associated with sponta ...... virus among illicit drug users
@ast
Factors associated with sponta ...... virus among illicit drug users
@en
Factors associated with sponta ...... virus among illicit drug users
@nl
P2093
P2860
P3181
P356
P1476
Factors associated with sponta ...... virus among illicit drug users
@en
P2093
Brian Conway
Calvin Lai
Jason Grebely
Jesse D Raffa
Mark W Tyndall
P2860
P304
P3181
P356
10.1155/2007/796325
P407
P50
P577
2007-07-01T00:00:00Z